Aethlon Medical - AEMD Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aethlon Medical in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" AEMD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AEMD, but not buy additional shares or sell existing shares.
View AEMD analyst ratings or view top-rated stocks.

1 equities research analysts have issued twelve-month price targets for Aethlon Medical's shares. Their AEMD share price forecasts range from $4.00 to $4.00. On average, they anticipate the company's share price to reach $4.00 in the next year. This suggests a possible upside of 938.4% from the stock's current price.
View analysts price targets for AEMD or view top-rated stocks among Wall Street analysts.

Aethlon Medical's stock was trading at $1.86 at the beginning of 2022. Since then, AEMD shares have decreased by 79.3% and is now trading at $0.3852.
View the best growth stocks for 2022 here.

Aethlon Medical saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 304,300 shares, an increase of 19.2% from the October 31st total of 255,300 shares. Based on an average daily trading volume, of 270,500 shares, the short-interest ratio is presently 1.1 days.
View Aethlon Medical's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, February 13th 2023.
View our AEMD earnings forecast.

Aethlon Medical, Inc. (NASDAQ:AEMD) issued its quarterly earnings results on Tuesday, November, 9th. The medical equipment provider reported ($0.13) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.15) by $0.02. The medical equipment provider had revenue of $0.13 million for the quarter, compared to the consensus estimate of $0.21 million. Aethlon Medical had a negative trailing twelve-month return on equity of 72.02% and a negative net margin of 3,542.86%. During the same period in the previous year, the business earned ($0.15) EPS.

Based on aggregate information from My MarketBeat watchlists, some companies that other Aethlon Medical investors own include Amarin (AMRN), Nokia Oyj (NOK), Vaxart (VXRT), VBI Vaccines (VBIV), Nabriva Therapeutics (NBRV), CRISPR Therapeutics (CRSP), Novavax (NVAX), OrganiGram (OGI), AT&T (T) and Aurora Cannabis (ACB).

Aethlon Medical trades on the NASDAQ under the ticker symbol "AEMD."

Aethlon Medical's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (6.33%), Citadel Advisors LLC (0.74%), Renaissance Technologies LLC (0.37%), Two Sigma Investments LP (0.34%), Buckingham Strategic Partners (0.30%) and Simplex Trading LLC (0.00%).
View institutional ownership trends.

Shares of AEMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AEMD stock can currently be purchased for approximately $0.39.

Aethlon Medical (NASDAQ:AEMD) has a market capitalization of $6.41 million and generates $290,000.00 in revenue each year. The medical equipment provider earns $-10,420,000.00 in net income (profit) each year or ($0.78) on an earnings per share basis.

Aethlon Medical's mailing address is 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123. The official website for the company is www.aethlonmedical.com. The medical equipment provider can be reached via phone at (858) 459-7800 or via email at susan@sanoonan.com.